miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

about

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

Item

http://www.wikidata.org/entity/Q57809343

description

im Oktober 2018 veröffentlichter wissenschaftlicher Artikel

@de

scientific article published on 19 October 2018

@en

wetenschappelijk artikel

@nl

наукова стаття, опублікована в жовтні 2018

@uk

name

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@en

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@nl

type

Item

label

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@en

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@nl

prefLabel

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@en

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@nl

P1476

miR-618: possible control over TIMP-1 and its expression in localized prostate cancer

@en

P2093

Caio Moura

http://www.w3.org/2001/XMLSchema#string

Denis R Morais

http://www.w3.org/2001/XMLSchema#string

Iran A Silva

http://www.w3.org/2001/XMLSchema#string

José Pontes-Junior

http://www.w3.org/2001/XMLSchema#string

Katia R Leite

http://www.w3.org/2001/XMLSchema#string

Miguel Srougi

http://www.w3.org/2001/XMLSchema#string

Nayara I Viana

http://www.w3.org/2001/XMLSchema#string

Sabrina T Reis

http://www.w3.org/2001/XMLSchema#string

William C Nahas

http://www.w3.org/2001/XMLSchema#string

P2860

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

Regulation of microRNA biogenesis

Promising Candidate Urinary MicroRNA Biomarkers for the Early Detection of Hepatocellular Carcinoma among High-Risk Hepatitis C Virus Egyptian Patients.

OncomiR-196 promotes an invasive phenotype in oral cancer through the NME4-JNK-TIMP1-MMP signaling pathway.

Serum metalloproteinases and their inhibitors: markers for malignant potential.

MicroRNA expression signatures during malignant progression from Barrett's esophagus to esophageal adenocarcinoma.

New molecular biomarkers for the prognosis and management of prostate cancer--the post PSA era.

Urine biomarkers in prostate cancer.

Molecular diagnosis of prostate cancer: are we up to age?

Identification of miR-1293 potential target gene: TIMP-1.

P2888

s12885-018-4930-4

P304

992

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/S12885-018-4930-4

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Renato F Ivanovic

P577

2018-10-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1107728105

http://www.w3.org/2001/XMLSchema#string

P698

30340564

http://www.w3.org/2001/XMLSchema#string

P921

cancer research

P932

6194613

http://www.w3.org/2001/XMLSchema#string